Agenus Inc AGEN:NASDAQ

RT Quote | NASDAQ | USD
Last | 03/03/21 EST
3.39quote price arrow down-0.26 (-7.24%)
Volume
3,505,172
52 week range
1.82 - 5.95

...

Loading . . .

KEY STATS

  • Open3.63
  • Day High3.68
  • Day Low3.39
  • Prev Close3.39
  • 52 Week High5.95
  • 52 Week High Date02/04/21
  • 52 Week Low1.82
  • 52 Week Low Date03/23/20
  • Market Cap645.56M
  • Shares Out190.15M
  • 10 Day Average Volume2.38M
  • Dividend-
  • Dividend Yield-
  • Beta1.47
  • 1 Year % Change35.8

RATIOS/PROFITABILITY

  • EPS (TTM)-1.09
  • P/E (TTM)-3.12
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-103.149M
  • ROE (MRQ)-421.78%
  • Revenue (MRQ)91.41M
  • Gross Margin (MRQ)44.02%
  • Net Margin (MRQ)-192.56%
  • Debt To Equity (MRQ)-12.25%

EVENTS

  • Earnings Date03/15/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Agenus Inc News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Agenus Inc. (Agenus) is an immuno-oncology (I-O) company. The Company focuses on the discovery and development of therapies that engage the body's immune system to fight cancer. It is developing a I-O portfolio driven by platforms and programs, such as antibody discovery platforms, including Retrocyte Display, SECANT yeast display and phage display technologies designed to produce human antibodies; antibody candidate programs, including checkpoint modulator (CPM) programs;...
Garo Armen Ph.D.
Chairman
Jennifer Buell
President
Christine Klaskin
Chief Accounting Officer
Donald Vidic
Vice President
Address
3 Forbes Rd
Lexington, MA
02421-7305
United States